Frederic Tort
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Molecular Biology top 2%
- DNA Repair Mechanisms
- Epigenetics and DNA Methylation
- Mitochondrial Function and Pathology
Papers in
-
- Metabolism and Genetic Disorders 17
-
- Biochemical Acid Research Studies 6
- Co-authors
- Jiřina BártkováTorben F. ØrntoftJiří BártekMaxwell SehestedPer GuldbergAlwin KrämerZuzana Hořejšı́Karsten Zieger
In The Last Decade
Frederic Tort
37 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.3k
- Molecular Biology 2.6k
- Cancer Research 550
- Clinical Biochemistry 223
- Pathology and Forensic Medicine 461
Countries citing papers authored by Frederic Tort
This map shows the geographic impact of Frederic Tort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Tort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Tort more than expected).
Fields of papers citing papers by Frederic Tort
This network shows the impact of papers produced by Frederic Tort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Tort. The network helps show where Frederic Tort may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frederic Tort, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 22 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 4 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2018 | 16 | |
| 14 | 2015 | 18 | |
| 15 | 2013 | 25 | |
| 16 | 2012 | 24 | |
| 17 | 2011 | 1 | |
| 18 | 2006 | 55 | |
| 19 | DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Hit paper breakdown → | 2005 | 2117 |
| 20 | 2004 | 27 |
About Frederic Tort
Frederic Tort is a scholar working on Clinical Biochemistry, Biochemistry, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 38 papers that have together received 3.4k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (17 papers), Mitochondrial Function and Pathology (14 papers), Biochemical and Molecular Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Cancer-related Molecular Pathways (6 papers), Biochemical Acid Research Studies (6 papers), DNA Repair Mechanisms (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Oncology (1.3k citations), Molecular Biology (2.6k citations), Cancer Research (550 citations), Clinical Biochemistry (223 citations) and Pathology and Forensic Medicine (461 citations). Frederic Tort has collaborated with scholars based in Spain, Germany and Denmark. Frequent co-authors include Jiřina Bártková, Torben F. Ørntoft, Jiří Bártek, Maxwell Sehested, Per Guldberg, Alwin Krämer, Zuzana Hořejšı́, Karsten Zieger, Karen Koed and Claudia Lukas. Their work appears in journals such as Journal of Inherited Metabolic Disease, Molecular Genetics and Metabolism, Journal of Clinical Medicine, Mitochondrion and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.